AKTX logo

Akari Therapeutics (AKTX) Operating Expenses

Annual Operating Expenses

$16.81 M
-$6.28 M-27.21%

December 31, 2023


Summary


Performance

AKTX Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAKTXexpensesmetrics:

Quarterly Operating Expenses

$1.85 M
-$3.70 M-66.66%

September 1, 2024


Summary


Performance

AKTX Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAKTXexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

AKTX Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-27.2%-66.7%
3 y3 years-6.5%+26.6%
5 y5 years-28.4%-40.6%

AKTX Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-27.2%at low-69.1%at low
5 y5-year-27.2%at low-76.3%+650.1%
alltimeall time-52.1%+2022.0%-83.0%>+9999.0%

Akari Therapeutics Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$1.85 M(-66.7%)
Jun 2024
-
$5.55 M(-7.2%)
Mar 2024
-
$5.99 M(+17.7%)
Dec 2023
$16.81 M(-27.2%)
$5.09 M(+103.0%)
Sep 2023
-
$2.51 M(-45.7%)
Jun 2023
-
$4.62 M(+0.5%)
Mar 2023
-
$4.59 M(-21.0%)
Dec 2022
$23.09 M(+34.1%)
-
Jun 2022
-
$5.82 M(+10.9%)
Mar 2022
-
$5.24 M(-10.7%)
Dec 2021
$17.21 M(-4.3%)
$5.87 M(+301.3%)
Sep 2021
-
$1.46 M(-66.2%)
Jun 2021
-
$4.33 M(-22.0%)
Mar 2021
-
$5.55 M(-19.5%)
Dec 2020
$17.98 M(+6.0%)
$6.90 M(+2692.8%)
Sep 2020
-
$246.90 K(-95.8%)
Jun 2020
-
$5.91 M(+20.0%)
Mar 2020
-
$4.93 M(-37.0%)
Dec 2019
$16.96 M(-27.8%)
$7.83 M(+151.1%)
Sep 2019
-
$3.12 M(-48.3%)
Jun 2019
-
$6.03 M(<-9900.0%)
Mar 2019
-
-$12.00 K(-100.2%)
Dec 2018
$23.49 M
$5.52 M(-3.0%)
DateAnnualQuarterly
Sep 2018
-
$5.69 M(-28.7%)
Jun 2018
-
$7.98 M(+85.3%)
Mar 2018
-
$4.31 M(-60.5%)
Dec 2017
$35.08 M(+28.8%)
$10.91 M(+27.7%)
Sep 2017
-
$8.54 M(+16.2%)
Jun 2017
-
$7.35 M(-11.3%)
Mar 2017
-
$8.28 M(-15.9%)
Dec 2016
$27.25 M(+141.1%)
$9.85 M(+63.6%)
Sep 2016
-
$6.02 M(-19.9%)
Jun 2016
-
$7.52 M(+95.2%)
Mar 2016
-
$3.85 M(-10.2%)
Dec 2015
$11.30 M(+488.8%)
$4.29 M(+6.1%)
Sep 2015
-
$4.04 M(+208.2%)
Jun 2015
-
$1.31 M(-20.7%)
Mar 2015
-
$1.65 M(+49.7%)
Dec 2014
$1.92 M(-46.8%)
$1.11 M(+406.9%)
Sep 2014
-
$218.00 K(-90.6%)
Jun 2014
-
$2.33 M(+23.7%)
Mar 2014
-
$1.88 M
Dec 2013
$3.61 M(-1.7%)
-
Dec 2012
$3.67 M(+63.2%)
-
Dec 2011
$2.25 M(+183.7%)
-
Dec 2010
$792.00 K
-

FAQ

  • What is Akari Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Akari Therapeutics?
  • What is Akari Therapeutics annual operating expenses year-on-year change?
  • What is Akari Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Akari Therapeutics?
  • What is Akari Therapeutics quarterly operating expenses year-on-year change?

What is Akari Therapeutics annual total operating expenses?

The current annual operating expenses of AKTX is $16.81 M

What is the all time high annual operating expenses for Akari Therapeutics?

Akari Therapeutics all-time high annual total operating expenses is $35.08 M

What is Akari Therapeutics annual operating expenses year-on-year change?

Over the past year, AKTX annual total operating expenses has changed by -$6.28 M (-27.21%)

What is Akari Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of AKTX is $1.85 M

What is the all time high quarterly operating expenses for Akari Therapeutics?

Akari Therapeutics all-time high quarterly total operating expenses is $10.91 M

What is Akari Therapeutics quarterly operating expenses year-on-year change?

Over the past year, AKTX quarterly total operating expenses has changed by -$3.70 M (-66.66%)